<DOC>
	<DOCNO>NCT00541606</DOCNO>
	<brief_summary>The purpose study demonstrate pharmacist work collaboratively physicians provider ambulatory care set improve glucose , blood pressure , lipid control , well improve quality life , adherence screen general preventative measure .</brief_summary>
	<brief_title>Pharmacist Assisted Medication Program Enhancing Regulation Diabetes</brief_title>
	<detailed_description>It evident multi-disciplinary approach key success control disease diabetes complication . The value pharmacists ' involvement disease state management produce positive outcome patient well documented literature . There several study show pharmacist ' involvement diabetes care improve glycemic control . There also study look pharmacist ' management glycemic control adherence ADA guideline . Many study retrospective , lack randomize control group , small study sample , short term . We undertake prospective , randomize study demonstrate pharmacist work collaboratively physicians provider ambulatory care set improve glucose , blood pressure , lipid control , well improve quality life , adherence screen general preventative measure .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients age 18 A1c &gt; 8 % within 6 month prior data acquisition date Primary Care physician Lahey Clinic Burlington site Diagnosis T2 DM minimum 6 month Concurrently enrol pharmacistrun diabetes study Receiving diabetes management outside provider A medical condition may adversely affect compliance treatment protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Diabetes Mellitus , Type 2</keyword>
	<keyword>Pharmaceutical Care</keyword>
	<keyword>Collaborative Practice</keyword>
</DOC>